| Lastest Insider Transactions Of Monte Rosa Therapeutics, Inc. ( GLUE ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | Chief Operating Officer | 2026-05-27 | Sell | 2,175 | 20.00 | 43,500 | 2026-05-28 19:10:37 |
| GLUE | Monte Rosa Therapeutics, Inc. | Champoux Jennifer | Chief Operating Officer | 2026-05-27 | Option Exercise | 2,175 | 3.98 | 8,657 | 2026-05-28 19:10:37 |
| GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | President & CEO | 2026-05-01 | Sell | 5,467 | 18.92 | 103,447 | 2026-05-05 16:05:03 |
| GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | President & CEO | 2026-04-14 | Sell | 8,000 | 17.64 | 141,125 | 2026-04-15 16:05:02 |
| GLUE | Monte Rosa Therapeutics, Inc. | Nickson Philip | Chief Business & Legal Officer | 2026-04-09 | Sell | 5,845 | 17.69 | 103,413 | 2026-04-10 16:07:54 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2026-03-04 | Sell | 139 | 17.96 | 2,496 | 2026-03-05 17:24:23 |
| GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | President & CEO | 2026-03-02 | Sell | 5,466 | 17.92 | 97,974 | 2026-03-04 16:50:05 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2026-02-27 | Sell | 25,700 | 18.09 | 464,886 | 2026-03-02 17:02:46 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2026-02-27 | Option Exercise | 25,700 | 13.41 | 344,637 | 2026-03-02 17:02:46 |
| GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Officer | 2026-02-23 | Sell | 9,189 | 19.50 | 179,161 | 2026-02-24 16:05:11 |
| GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | President & CEO | 2026-01-07 | Sell | 5,466 | 23.49 | 128,373 | 2026-01-09 16:05:17 |
| GLUE | Monte Rosa Therapeutics, Inc. | Janku Filip | Chief Medical Officer | 2026-01-02 | Sell | 3,155 | 15.17 | 47,861 | 2026-01-05 16:04:31 |
| GLUE | Monte Rosa Therapeutics, Inc. | Townson Sharon | Chief Scientific Officer | 2026-01-02 | Sell | 3,155 | 15.17 | 47,861 | 2026-01-05 16:04:07 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2025-06-03 | Sell | 2,062 | 4.45 | 9,174 | 2025-06-04 16:15:08 |
| GLUE | Monte Rosa Therapeutics, Inc. | Leo Chandra P. | Directior | 2025-03-24 | Buy | 10,000 | 5.84 | 58,383 | 2025-03-25 18:32:00 |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-10-28 | Sell | 157,895 | 9.44 | 1,491,041 | 2024-10-30 16:35:43 |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-09-20 | Sell | 1,132,566 | 6.53 | 7,395,203 | 2024-09-24 16:40:59 |
| GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-09-11 | Sell | 567,213 | 6.00 | 3,404,791 | 2024-09-13 18:44:19 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2024-07-05 | Sell | 1,610 | 3.83 | 6,166 | 2024-07-09 16:15:03 |
| GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2024-06-03 | Sell | 1,207 | 4.04 | 4,876 | 2024-06-05 16:10:07 |
